Symposium on 'nutrition in the post-genomic era'. Plenary session 4: Genetic variation and diet-related disease: Gene polymorphisms, inflammatory diseases and cancer

Proceedings of the Nutrition Society

Volumn 61, Issue 4, 2002, Pages 447-456

  Howell, W Martin ^a   Calder, Philip C ^c   Grimble, Robert F ^b  

^a UNIVERSITY HOSPITAL SOUTHAMPTON NHS FOUNDATION TRUST   (United Kingdom)

^b UNIVERSITY OF SOUTHAMPTON   (United Kingdom)

^c NONE

Author keywords

Cancer; Cytokine genes; Gene polymorphisms; Human leucocyte antigen genes; Inflammatory diseases

Indexed keywords

ANTIGEN; CYTOKINE; GENE PRODUCT; HLA ANTIGEN; HLA DQ ANTIGEN;

ALLELE; ANTIGEN PRESENTATION; CANCER; CELIAC DISEASE; CONFERENCE PAPER; CYTOKINE PRODUCTION; DISEASE PREDISPOSITION; GENETIC POLYMORPHISM; GENETIC RISK; GLUTEN FREE DIET; HLA SYSTEM; HUMAN; IMMUNE RESPONSE; IMMUNOLOGICAL TOLERANCE; IMMUNOREGULATION; INFLAMMATION; MELANOMA; MULTIGENE FAMILY; PROGNOSIS; PROMOTER REGION; PROTEIN MOTIF; RISK FACTOR; SKIN CANCER; SOLID TUMOR; WHEAT; DIET; GENETIC PREDISPOSITION; GENETICS; IMMUNITY; NEOPLASM; REVIEW; RHEUMATOID ARTHRITIS;

TRITICUM AESTIVUM;

ARTHRITIS, RHEUMATOID; CELIAC DISEASE; CYTOKINES; DIET; GENETIC PREDISPOSITION TO DISEASE; HLA ANTIGENS; HUMANS; IMMUNITY; INFLAMMATION; NEOPLASMS; POLYMORPHISM, GENETIC; PROMOTER REGIONS (GENETICS);

EID: 0036871006     PISSN: 00296651     EISSN: None     Source Type: Journal    
DOI: 10.1079/PNS2002186     Document Type: Conference Paper

References (85)

1. Allen RD (1999) Polymorphism of the human TNF-α promoter - random variation or functional diversity? Molecular Immunology 36, 1017-1027.
2. Arentz-Hansen H, Komer R, Molberg O, Quartsen H, Vader W, Kooy YMC, Lundin KEA, Koning F, Roepstorff P, Sollid LM & McAdam SN (2000) The intestinal T cell response to α-gliadin in adult celiac disease is focused on a single deamidated glutamine targeted by tissue transglutaminase. Journal of Experimental Medicine 191, 603-612.
3. Arguello JR, Little A-M, Bohan E, Goldman J, Marsh SG & Madrigal JA (1998) High resolution HLA class I typing by Reference Strand Mediated Conformation Analysis (RSCA). Tissue Antigens 52, 57-66.
4. Bateman AC, Hemmatpour SK, Theaker JM & Howell WM (1997) Nested polymerase chain reaction-based HLA class II typing for the unique identification of formalin-fixed and paraffin-embedded tissue. Journal of Pathology 181, 228-234.
5. Bateman AC & Howell WM (1999) Human leukocyte antigens and cancer: is it in our genes? Journal of Pathology 188, 231-236.
6. Bateman AC, Leung ST, Howell WM, Roche WR, Jones DB & Theaker JM (1994) Detection of specimen contamination in routine histopathology by HLA class II typing using the polymerase chain reaction and sequence specific oligonucleotide probing. Journal of Pathology 173, 243-248.
7. Bateman AC, Sage DA, Al-Talib RK, Theaker JM, Jones DB & Howell WM (1996) Investigation of specimen mislabelling in paraffin-embedded tissue using a rapid, allele-specific, PCR-based HLA class II typing method. Histopathology 28, 169-174.
8. Bateman AC, Turner SJ, Theaker JM & Howell WM (1998) HLA-DQB1*0303 and *0301 alleles influence susceptibility to and prognosis in cutaneous malignant melanoma in the British caucasian population. Tissue Antigens 52, 67-73.
9. Bateman AC, Turner SJ, Theaker JM, Warren BF & Howell WM (1999) Polymerase chain reaction-based human leukocyte antigen genotyping for the investigation of suspected gastrointestinal biopsy contamination. Gut 45, 259-263.
10. Baum H, Davies H & Peakman M (1996) Molecular mimicry in the MHC: hidden clues to autoimmunity? Immunology Today 17, 64-70.
11. Belluzzi A, Brignola C, Campieri M, Pera A, Boschi S & Miglioli M (1996) Effect of an enteric coated fish oil preparation on relapses in Crohn's disease. New England Journal of Medicine 334, 1557-1616.
12. Bidwell J, Keen L, Gallagher G, Kimberly R, Huinzinga T, McDermott MF, Oksenberg J, McNicholl J, Pociot F, Hardt C & D'Alfonso S (1999) Cytokine gene polymorphism in human disease: on-line databases. Genes and Immunity 1, 3-19.
13. Bidwell J & Navarrete C (2000) Histocompatibility Testing. London: Imperial College Press.
14. Bidwell JL, Bidwell EA, Savage DA, Middleton D, Klouda PT & Bradley BA (1988) A DNA-RFLP typing system that positively identifies serologically well-defined and ill-defined HLA-DR and DQ alleles, including DRw10. Transplantation 45, 640-646.
15. Blasczyk R, Hahn U, Wehling J, Huhn D & Salama A (1995) Complete subtyping of the HLA-A locus by sequence-specific amplification followed by direct sequencing or single-strand conformation polymorphism analysis. Tissue Antigens 46, 86-95.
16. Bodmer JG, Tonks S, Oza AM, Mikata A, Takenouchi T, Lister TA & collaborating centres (1992) Hodgkin's disease study. In HLA 1991, vol. 1, pp. 701-709 [K Tsuji, M Aizawa and T Sasazuki, editors]. Oxford: Oxford University Press.
17. Bouma G, Oudkerk Pool M, Crusius JB, Schreuder GM, Hellemans HP, Meijer BU, Kostense PJ, Giphart MJ, Meuwissen SG & Pena AS (1997) Evidence for genetic heterogeneity in inflammatory bowel disease (IBD); HLA genes in the predisposition to suffer from ulcerative colitis (UC) and Crohn's disease (CD). Clinical and Experimental Immunology 109, 175-179.
18. Brinkman BM, Huizinga TW, Kurban SS, van der Velde EA, Schreuder GM, Hazes JM, Breeveld FC & Verweij CL (1997) Tumour necrosis factor alpha gene polymorphisms in rheumatoid arthritis: association with susceptibility to, or severity of, disease? British Journal of Rheumatology 36, 516-521.
19. Calder PC (2001) Polyunsaturated fatty acids, inflammation and immunity. Lipids 36, 1007-1024.
20. Caughey GE, Mantzioris E, Gibson RA, Cleland LG & James MJ (1996) The effect on human tumor necrosis factor alpha and interleukin 1 beta production of diets enriched in n-3 fatty acids from vegetable oil or fish oil. American Journal of Clinical Nutrition 63, 116-122.
21. Chouchane L, Ben Ahmed S, Baccouche S & Remadi S (1997) Polymorphism in the tumour necrosis factor-α promotor region and in the heat shock protein 70 genes associated with malignant tumours. Cancer 80, 1489-1496.
22. Clark WH Jr, Elder DE, Guerry D IV, Braitman LE, Trock BJ, Schultz D, Synnestvedt M & Halpern AC (1989) Model predicting survival in stage I melanoma based on tumour progression. Journal of the National Cancer Institute 81, 1893-1904.
23. Culig Z, Hobisch A, Herold M, Hittmair A, Thurnher M, Eder IE, Cronauer MV, Rieser C, Ramoner R, Bartsch G, Klocker H & Konwalinka G (1998) Interleukin 1 beta mediates the modulatory effects of monocytes on LNCaP human prostate cancer cells. British Journal of Cancer 78, 1004-1011.
24. Demeter J, Porzsolt F, Ramisch S, Schmidt D, Schmid M & Messer G (1997) Polymorphism of the tumour necrosis factor-alpha and lymphotoxin-alpha genes in chronic lymphocytic leukaemia. British Journal of Haematology 97, 107-112.
25. Dummer W, Becker JC, Schwaaf A, Leverkus M, Moll T & Brocker EB (1995) Elevated serum levels of interleukin-10 in patients with metastatic malignant melanoma. Melanoma Research 5, 67-68.
26. Fishman D, Faulds G, Jeffery R, Mohamed-Ali V, Yudkin JS, Humphries S & Woo P (1998) The effect of novel polymorphisms in the interleukin-6 (IL-6) gene on IL-6 transcription and plasma IL-6 levels, and an association with systemic-onset juvenile chronic arthritis. Journal of Clinical Investigation 102, 1369-1376.
27. Fox DA (1997) The role of T cells in the immunopathogenesis of rheumatoid arthritis: new perspectives. Arthritis and Rheumatism 40, 598-609.
28. Grimble R, Calder P, Howell W, O'Reilly G, Hirrell S, Turner S, Markovic O & East M (2002) Associations between polymorphisms in the lymphotoxin-α (LT-α) and tumour necrosis factor-α (TNF-α) genes and the ability of fish oil to suppress TNF-α production by peripheral blood mononuclear cells (PBMC) in healthy men. American Journal of Clinical Nutrition 76, 454-459.
29. Grimble RF (1996) Interaction between nutrients, pro-inflammatory cytokines and inflammation. Clinical Science 91, 121-130.
30. Hajeer AH, Lazarus M, Turner D, Mageed RA, Vencovsky J, Sinnott PJ, Hutchinson IV & Ollier WE (1998) IL-10 gene promoter polymorphisms in rheumatoid arthritis. Scandinavian Journal of Rheumatology 27, 142-145.
31. Hemmatpour SK, Dunn PPJ, Evans PR, Green A & Howell WM (1998) Functional characterization and exon 2-intron 2-exon 3 gene sequence of HLA-B*2712 as found in a British family. European Journal of Immunogenetics 25, 395-402.
32. Howell WM, Bateman AC, Turner SJ, Collins A & Theaker JM (2002a) Influence of vascular endothelial growth factor single nucleotide polymorphisms on tumour development in cutaneous malignant melanoma. Genes and Immunity 3, 229-232.
33. Howell WM, Leung ST, Jones DB, Nakshabendi I, Hall MA, Lanchbury JS, Ciclitira PJ & Wright DH (1995) HLA-DRB, DQA and DQB polymorphism in celiac disease and enteropathy-associated T cell lymphoma: common features and additional risk factors for malignancy. Human Immunology 43, 29-37.
34. Howell WM, & Poole KL (2002) The special case of HLA genes: detection and resolution of multiple polymorphic sites within a single gene. In Molecular Genetic Epidemiology - A Laboratory Perspective, pp. 131-152. [INM Day, editor]. Heidelberg: Springer.
35. Howell WM, Turner SJ, Bateman AC & Theaker JM (2001) Il-10 promoter polymorphisms influence tumour development in cutaneous malignant melanoma. Genes and Immunity 2, 25-31.
36. Howell WM, Turner SJ, Collins A, Bateman AC & Theaker JM (2002b) Influence of TNFα and LTα single nucleotide polymorphisms on susceptibility to and prognosis in cutaneous malignant melanoma in the British population. European Journal of Immunogenetics 29, 17-23.
37. Huang S, Ullrich SE & Bar-Eli M (1999) Regulation of tumour growth and metastasis by interleukin-10: the melanoma experience. Journal of Interferon and Cytokine Research 19, 697-703.
38. Jacob CO, Franek Z, Lewis GD, Koo M, Hansen JA & McDevitt HO (1990) Heritable major histocompatibility complex class II-associated differences in production of tumor necrosis factor-α: relevance to genetic predisposition to systemic lupus erythematosus. Proceedings of the National Academy of Sciences USA 87, 1233-1237.
39. John S, Myerscough A, Marlow A, Hajeer A, Silman A, Ollier W & Worthington J (1998) Linkage of cytokine genes to rheumatoid arthritis. Evidence of genetic heterogeneity. Annals of the Rheumatic Diseases 57, 361-365.
40. Karhukorpi J & Karttunen R (2001) Genotyping interleukin-10 high and low producers with single-tube bi-directional allele-specific amplification. Experimental and Clinical Immunogenetics 18, 67-70.
41. Kay RA (1996) TCR gene polymorphisms and autoimmune disease. European Journal of Immunogenetics 23, 161-177.
42. Klein J & Sato A (2000) The HLA system. Second of two parts. New England Journal of Medicine 343, 782-786.
43. Knight JC & Kwiatowski D (1999) Inherited variability of tumor necrosis factor production and susceptibility to infectious disease. Proceedings of the Association of American Physicians 111, 290-298.
44. Knight JC, Udalova I, Hill AVS, Greenwood BM, Peshu N, Marsh K & Kwiatowski D (1999) A polymorphism that affects OCT-1 binding to the TNF promoter region is associated with severe malaria. Nature Genetics 22, 145-150.
45. Krausa P & Browning M (1996) Detection of HLA gene polymorphism. In HLA and MHC: Genes, Molecules and Function, pp. 113-137 [M Browning and A McMichael, editors]. Oxford: BIOS Scientific Publishers Ltd.
46. Kremer JM (2000) n-3 fatty acid supplements in rheumatoid arthritis. American Journal of Clinical Nutrition 71, 3495-3515.
47. Kroeger KM, Steer JH, Joyce DA & Abraham LJ (2000) Effects of stimulus and cell type on the expression of the -308 tumour necrosis factor promoter polymorphism. Cytokine 12, 110-119.
48. Kutukculer N, Shenton BK, Clark K, Rigg KM, Forsythe JL, Kirby JA, Proud G & Taylor RM (1995) Renal allograft rejection: temporal relationship and predictive value of plasma TNF (alpha and beta), IFN-gamma and soluble ICAM-1. Transplant International 8, 45-50.
49. Lazarus M, Hajeer AH, Turner D, Sinnott P, Worthington J, Ollier WE & Hutchinson IV (1997) Genetic variation in the interleukin 10 gene promoter and systemic lupus erythematosus. Journal of Rheumatology 24, 2314-2317.
50. Lechler R & Warrens A (2000) HLA in Health and Disease, 2nd ed. London: Academic Press Ltd.
51. Le Drean E, Gervois N, Diez E, Semana G, Dreno B & Jotreau F (1995) HLA class II-restricted recognition of common tumour epitopes on human melanoma cells by CD4+ melanoma-infiltrating lymphocytes. European Journal of Immunology 25, 2732-2736.
52. Leek RD, Lewis CE, Whitehouse R, Greenall M, Clarke J & Harris AL (1996) Association of macrophage infiltration with angiogenesis and prognosis in invasive breast carcinoma. Cancer Research 56, 4625-4629.
53. Lim S, Crawley E, Woo P & Barnes PJ (1998) Haplotype associated with low interleukin-10 production in patients with severe asthma (letter). Lancet 352, 113.
54. McCarron SL, Edwards S, Evans PR, Gibbs R, Deamaley DP, Dowe A, Southgate D, The CRC/BPG UK Familial Prostate Cancer Study Collaborators, Easton DF, Eeles RA & Howell WM (2002) Influence of cytokine gene polymorphisms on the development of prostate cancer. Cancer Research 62, 3369-3372.
55. Maini RN & Taylor PC (2000) Anti-cytokine therapy for rheumatoid arthritis. Annual Review of Medicine 51, 207-229.
56. Marshall SE, McLaren AJ, Haldar NA, Bunce M, Morris PJ & Welsk KI (2000) The impact of recipient cytokine genotype on acute rejection after renal transplantation. Transplantation 70, 1485-1491.
57. Mayser P, Mrowietz U, Arenberger P, Bartak P, Buchwald J, Christophers E, Jablonska S, Salmhofer W, Schill WB, Kramer HJ, Schlotzer E, Mayer K, Seeger W & Grimminger F (1998) Omega-3 fatty acid-based lipid infusion in patients with chronic plaque psoriasis: results of a double-blind, randomized, placebo-controlled, multicenter trial. Journal of the American Academy of Dermatology 38, 539-547.
58. Messer G, Spengler U, Jung MC, Honold G, Blomer K, Pape GR, Riethmuller G & Weiss EH (1991) Polymorphic structure of the tumor necrosis factor (TNF) locus: an NcoI polymorphism in the first intron of the human TNF-α gene correlates with a variant amino acid in position 26 and a reduced level of TNF-α production. Journal of Experimental Medicine 173, 209-219.
59. Mittal KK, Mickey MR, Singal DP & Terasaki PI (1968) Serotyping for homotransplantation: refinement of microdroplet lymphocyte cytotoxicity test. Transplantation 6, 913-927.
60. Moffatt MF & Cookson WO (1997) Tumour necrosis factor haplotypes and asthma. Human Molecular Genetics 6, 551-554.
61. Murch SH, Lamkin VA, Savage MO, Walker-Smith JA & MacDonald TT (1991) Serum concentrations of tumour necrosis factor-α in childhood chronic inflammatory bowel disease. Gut 32, 913-917.
62. Nepom GT (2000) HLA and type I diabetes. In HLA in Health and Disease, 2nd ed., pp. 231-237 [R Lechler and A Warrens, editors]. London: Academic Press Ltd.
63. Nepom GT, Gersuk V & Nepom BS (1996) Prognostic implications of HLA genotyping in the early assessment of patients with rheumatoid arthritis. Journal of Rheumatology 23, 5-9.
64. Olerup O & Zetterquist H (1992) HLA-DR typing by PCR amplification with sequence-specific primers (PCR-SSP) in 2 hours: An alternative to serological DR typing in clinical practice including donor-recipient matching in cadaveric transplantation. Tissue Antigens 39, 225-235.
65. Ollier W & Thomson W (1992) Population genetics of rheumatoid arthritis. In Rheumatic Disease Clinics of North America, pp. 741-759 [GT Nepom, editor]. Philadelphia, PA: WB Saunders.
66. Perrey C, Pravica V, Sinnott PJ & Hutchinson IV (1998) Genotyping for polymorphisms in interferon-γ, interleukin-10, transforming growth factor-β1 and tumour necrosis factor-α genes: a technical report. Transplant Immunology 6, 193-197.
67. Poole KL, Gibbs PJ, Evans PR, Sadek SA & Howell WM (2001) Influence of patient and donor cytokine genotypes on renal allograft rejection: evidence from a single study. Transplant Immunology 8, 259-265.
68. Robinson J, Waller MJ, Parham P, Bodmer JG & Marsh SGE (2001) IMGT/HLA Database - a sequence database for the human major histocompatibility complex. Nucleic Acids Research 29, 210-213.
69. Ross J (2000) Sequencing-based typing. In Histocompatibility Testing, pp. 213-246 [J Bidwell and C Navarrete, editors]. London: Imperial College Press.
70. Ross R (1993) The pathogenesis of atherosclerosis: a perspective for the 1990s. Nature 362, 801-809.
71. Sankaran D, Ashraf S, Martin S, Roberts I, Short C, Dyer PA, Sinnott PJ & Hutchinson IV (1998) High interleukin 10 producer genotype is not protective against renal allograft rejection in high TNFα producers. European Journal of Immunogenetics 25, 68.
72. Schulman CC, Ekane S & Zlotta AR (2001) Nutrition and prostate cancer: evidence or suspicion? Urology 58, 318-334.
73. Scott H, Nilsen E, Sollid LM, Lundin KE, Rugtveit J, Molberg O, Thorsby E & Brandtzaeg P (1997) Immunopathology of gluten-sensitive enteropathy. Springer Seminars in Immunopathology 18, 535-553.
74. Sollid LM, Spurkland A & Thorsby E (2000) HLA and gastro-intestinal diseases. In HLA in Health and Disease, 2nd ed., pp. 249-262 [R Lechler and A Warrens, editors]. London: Academic Press Limited.
75. Sollid LM & Thorsby E (1993) HLA susceptibility genes in celiac disease: genetic mapping and role in pathogenesis. Gastroenterology 105, 910-922.
76. Sorrentino R & Tosi R (1997) HLA-B27 subtypes: ankylosing spondylitis association versus peptide binding specificity. In HLA-B27 in the Development of Spondyloarthropathies, pp. 135-144 [C López-Larrea, editor]. Heidelberg: Springer.
77. Taylor GM, Dearden S, Payne N, Ayres M, Gokhale DA, Birch JM, Blair V, Stevens RF, Will AM & Eden OB (1998) Evidence that an HLA-DQA1-DQB1 haplotype influences susceptibility to childhood common acute lymphoblastic leukaemia in boys provides further support for an infection-related aetiology. British Journal of Cancer 78, 561-565.
78. Thorsby E (1997) Invited anniversary review: HLA associated diseases. Human Immunology 53, 1-11.
79. Turner D, Grant S, Yonan N, Sheldon S, Dyer PA, Sinnott PJ & Hutchinson IV (1997a) Cytokine gene polymorphism and heart transplant rejection. Transplantation 64, 776-779.
80. Turner DM, Williams DM, Sankaran D, Lazarus M, Sinnott PJ & Hutchinson IV (1997b) An investigation of polymorphism in the interleukin-10 gene promoter. European Journal of Immunogenetics 24, 1-8.
81. Uryu N, Maeda M, Ota M, Tsuji K & Inoko H (1990) A simple and rapid method for HLA-DRB and -DQB typing by digestion of PCR-amplified DNA with allele specific restriction endonucleases. Tissue Antigens 35, 20-31.
82. van der Poll T & van Deventer SJ (1999) Cytokines and anticytokines in the pathogenesis of sepsis. Infectious Disease Clinics of North America 13, 413-426.
83. Vesalainen S, Lipponen R, Talja M & Syrjanen K (1994) Histological grade, perineural infiltration, tumour infiltrating lymphocytes and apoptosis as determinants of long-term prognosis in prostatic adenocarcinoma. European Journal of Cancer 30A, 1797-1803.
84. Westendorp RG, Langermans JAM, Huizinga TW, Verweij CL & Sturk A (1997) Genetic influence on cytokine production and fatal meningococcal disease. Lancet 349, 170-173.
85. Ye S, Dillon S, Ke X, Collins AR & Day INM (2001) An efficient procedure for genotyping single nucleotide polymorphisms. Nucleic Acids Research 29, e88.